TNF and colitis: Intraperitoneal administration of the minor tobacco alkaloid and nicotinic receptor agonist anabaseine was shown to reduce tissue damage, myeloperoxidase activity, and colonic TNFα expression in a TNBS mouse model of colitis [22].